Nonresectional regional therapies for metastatic colorectal cancer to the liver
- PMID: 30825217
- DOI: 10.1002/jso.25423
Nonresectional regional therapies for metastatic colorectal cancer to the liver
Abstract
The liver is the second leading site of colorectal cancer metastases, following the lymph nodes. Although metastatic resection for colorectal cancer liver metastases has been shown to improve survival, many patients cannot undergo surgery. Several nonsurgical therapies are available in these situations, however high-quality evidence comparing the effectiveness of these therapies is sparse. Here, we review the currently available evidence in support of nonresectional regional therapies for colorectal metastases to the liver.
Keywords: colorectal cancer; hepatic metastases; liver-directed therapy; metastatic colorectal cancer; regional therapies.
© 2019 Wiley Periodicals, Inc.
Similar articles
-
Liver-directed therapy in metastatic colorectal cancer.Expert Rev Anticancer Ther. 2017 Aug;17(8):745-758. doi: 10.1080/14737140.2017.1345629. Epub 2017 Jun 28. Expert Rev Anticancer Ther. 2017. PMID: 28636427 Review.
-
The state of regional therapy in the management of metastatic colorectal cancer to the liver.Expert Rev Anticancer Ther. 2016;16(2):229-45. doi: 10.1586/14737140.2016.1129277. Epub 2016 Jan 13. Expert Rev Anticancer Ther. 2016. PMID: 26652741 Review.
-
Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.J Surg Oncol. 2014 Aug;110(2):182-96. doi: 10.1002/jso.23619. Epub 2014 Apr 24. J Surg Oncol. 2014. PMID: 24760444 Review.
-
Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities.Hepatogastroenterology. 2001 Mar-Apr;48(38):305-12. Hepatogastroenterology. 2001. PMID: 11379296 Review.
-
What, how, and when to offer nonresectional therapy for colorectal cancer liver metastases.J Gastrointest Surg. 2011 Mar;15(3):420-2. doi: 10.1007/s11605-011-1428-7. Epub 2011 Jan 25. J Gastrointest Surg. 2011. PMID: 21264686 No abstract available.
Cited by
-
Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Shikonin in Colon Cancer.Front Pharmacol. 2020 Oct 22;11:544647. doi: 10.3389/fphar.2020.544647. eCollection 2020. Front Pharmacol. 2020. PMID: 33281602 Free PMC article.
-
Surgical and Interventional Management of Liver Metastasis.Clin Colon Rectal Surg. 2022 Dec 9;37(2):80-84. doi: 10.1055/s-0042-1758822. eCollection 2024 Mar. Clin Colon Rectal Surg. 2022. PMID: 38322597 Free PMC article. Review.
-
Integrated proteomics and metabolomics reveals the comprehensive characterization of antitumor mechanism underlying Shikonin on colon cancer patient-derived xenograft model.Sci Rep. 2020 Aug 24;10(1):14092. doi: 10.1038/s41598-020-71116-5. Sci Rep. 2020. PMID: 32839531 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical